Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 278, Issue 4 22-4, 2000, Pages

  Muzykantov, V R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute lung injury; CD31; Drug delivery; Hydrogen peroxide; Isoprostane; Oxidative stress; Platelet endothelial Cell adhesion molecule 1

Indexed keywords

CD31 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; ISOPROSTANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL CULTURE; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; ENZYME ACTIVITY; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 12944309831     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.278.4.l794     Document Type: Article

References (45)

1. Al-Mehdi A, Shuman H, and Fisher AB. Fluorescence microphotography of oxidative stress in lung ischemia-reperfusion. Lab Invest 70: 579-587, 1994.
2. Atochina EN, Balyasnikova IV, Danilov SM, Granger DN, Fisher AB, and Muzykantov VR. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am J Physiol Lung Cell Mol Physiol 275: L806-L817, 1998.
3. Atochina EN, Muzykantov VR, Al-Mehdi AB, Danilov SM, and Fisher AB. Normoxic lungs ischemia/reperfusion accelerates shedding of angiotensin converting enzyme from the pulmonary endothelium. Am J Respir Crit Care Med 156: 1114-1119, 1997.
4. 2-isoprostane generation in isolated ferret lungs after oxidant injury or ventilated ischemia. Free Radic Biol Med 25: 703-711, 1998.
5. Brigham K and Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 133: 913-927, 1986.
6. Chabot F, Mitchell JA, Gutteridge JM, and Evans TW. Reactive oxygen species in acute lung injury. Eur Respir J 11: 745-757, 1998.
7. Christofidou-Solomidou M, Longley J, Whitaker-Menezes D, Albelda SM, and Murphy GF. Human skin/SCID mouse chimeras as an in vivo model to study human cutaneous mastocytosis. J Invest Dermatol 109: 102-107, 1997.
8. Danilov S, Muzykantov V, Martynov A, Atochina E, Sakharov I, Trakht I, and Smirnov V. Lung is a target organ for monoclonal antibody to ACE. Lab Invest 64: 118-124, 1991.
9. DeLisser HM, Newman PJ, and Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 15: 490-495, 1994.
10. Fisher AB, Dodia C, Tan Z, Ayene I, and Eckenhoff RG. Oxygen-dependent lipid peroxidation during lung ischemia. J Clin Invest 88: 674-679, 1991.
11. Freeman B and Crapo J. Free radicals and tissue injury. Lab Invest 47: 412-426, 1987.
12. Friedland J and Silverstein E. A sensitive fluorimetric assay for serum ACE. Am J Clin Pathol 66: 416-424, 1976.
13. Fulkerson WJ, MacIntyre N, Stamler J, and Crapo JD. Pathogenesis and treatment of the acute respiratory distress syndrome. Arch Intern Med 156: 29-38, 1996.
14. Gibbons G and Dzau V. Molecular therapies for vascular diseases. Science 272: 689-693, 1996.
15. 2 and endothelial oxidative stress. Am J Physiol Lung Cell Mol Physiol 277: L271-L281, 1999.
16. Halliwell B and Gutteridge J. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 246: 501-514, 1986.
17. Huang X, Molema G, King S, Watkins L, Edgington TS, and Thorpe PE. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 275: 547-550, 1997.
18. Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 23: 21-48, 1993.
19. Kennel S, Lee R, Bultman S, and Kabalka G. Rat monoclonal antibody distribution in mice: an epitope inside the lung vascular space mediates very efficient localization. Int J Rad Appl Instrum B 17: 193-200, 1990.
20. McIntyre TM, Modur V, Prescott SM, and Zimmerman GA. Molecular mechanisms of early inflammation. Thromb Hemostasis 78: 302-305, 1997.
21. Muzykantov V, Peklo M, and Printzeva O. Local tissue injury induced by glucose oxidase conjugated with anti-collagen antibody. J Immunol Methods 119: 65-73, 1989.
22. Muzykantov V, Sakharov D, Sinitsyn V, Goncharov N, and Danilov S. Specific killing of human endothelial cells by antibody-conjugated glucose oxidase. Anal Biochem 169: 383-389, 1988.
23. Muzykantov V, Trubetskaja O, Puchnina E, Sakharov D, and Domogatsky S. Cytotoxicity of glucose oxidase conjugated with antibodies to target cells: efficiency of killing depends on the conjugate internalization. Biochim Biophys Acta 1053: 27-31, 1990.
24. Muzykantov VR. Conjugation of catalase to a carrier antibody via streptavidin-biotin cross-linker. Biotechnol Appl Biochem 26: 103-109, 1997.
25. Muzykantov VR. Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy. Pathophysiology 5: 15-33, 1998.
26. Muzykantov VR, Atochina E, Ischiropoulos H, Danilov S, and Fisher AB. Immunotargeting of antioxidant enzymes to the pulmonary endothelium. Proc Natl Acad Sci USA 93: 5213-5218, 1996.
27. Muzykantov VR, Barnathan ES, Atochina E, Kuo A, Danilov S, and Fisher AB. Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature. J Pharmacol Exp Ther 279: 1026-1034, 1996.
28. Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I, Harshaw D, Schultz L, Fisher A, and Albelda S. Streptavidin facilitates internalization and pulmonary uptake of an anti-endothelial cell antibody (PECAM-1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci USA 96: 2379-2384, 1999.
29. Muzykantov VR, Martynov AV, Puchina EA, and Danilov SM. In vivo administration of glucose oxidase conjugated with monoclonal antibodies to angiotensin-converting enzyme. Am Rev Respir Dis 139: 1464-1473, 1989.
30. Natarajan V. Oxidants and signal transduction in vascular endothelium. J Lab Clin Med 125: 26-37, 1995.
31. Nathan C and Cohn Z. Antitumor effects of hydrogen peroxide in vivo. J Exp Med 154: 1539-1553, 1981.
32. Newman PJ. The biology of PECAM. J Clin Invest 99: 3-7, 1997.
33. Panes J, Perry M, Anderson D, Muzykantov V, Garden D, Miyasaka M, and Granger D. Portal hypertension enhances endotoxin-induced ICAM-1 up- regulation in the rat. Gastroenterology 110: 866-874, 1996.
34. Patrono C and FitzGerald G. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17: 2309-2315, 1997.
35. Philpott GW, Kulczycky A, Grass EH, and Parker CW. Selective binding and cytotoxicity of rat basophyllic leukemia cells with immunoglobulin E-biotin and avidin-glucose oxidase conjugates. J Immunol 125: 1201-1208, 1980.
36. Poznansky MJ and Juliano RL. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev 36: 277-334, 1984.
37. Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Maclouf J, Violi F, and FitzGerald GA. Localization of distinct F-2-isoprostanes in human atherosclerotic lesions. J Clin Invest 100: 2028-2034, 1997.
38. Pratico D, Tangilla R, Rader D, Rokach J, and FitzGerald GA. Vitamin E suppresses isoprostane generation and reduced atherosclerosis. Nat Med 4: 1189-1192, 1992.
39. Rokach J, Khanapure SP, Hwang S-W, Adiyaman M, Lawson JA, and FitzGerald GA. Nomenclature of isoprostanes: a proposal. Prostaglandins 54: 853-873, 1997.
40. Schnitzer JE. Vascular targeting as a strategy for cancer therapy. N Engl J Med 339: 472-474, 1998.
41. Thomas JR, Harlan JM, Rice CL, and Winn RK. Role of leukocyte CD11/CD18 complex in endotoxic and septic shock in rabbits. J Appl Physiol 73: 1510-1516, 1992.
42. Trubetskoy V, Torchilin V, Kennel S, and Huang L. Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly-(L-lysine)-antibody conjugate in mouse lung endothelial cells. Biochim Biophys Acta 1131: 311-313, 1992.
43. Vaporciyan AA, Delisser HM, Yan H-C, Mendiguren I, Thom SR, Jones ML, Ward PA, and Albelda SM. Involvement of PECAM-1 in neutrophil recruitment in vivo. Science 262: 1580-1582, 1993.
44. 2α excretion in man. J Pharmacol Exp Ther 275: 94-100, 1995.
45. Yan H, Baldwin S, Sun J, Buck C, Albelda SM, and DeLisser M. Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of mouse PECAM-1. J Biol Chem 270: 23672-23680, 1995.